Diehm C, Trampisch H J, Lange S, Schmidt C
Department of Internal Medicine/Vascular Medicine, Affiliated Teaching Hospital, University of Heidelberg, Germany.
Lancet. 1996 Feb 3;347(8997):292-4. doi: 10.1016/s0140-6736(96)90467-5.
Diseases of the venous system are widespread disorders sometimes associated with modern civilisation and are among the major concerns of social and occupational medicine. This study was carried out to compare the efficacy (oedema reduction) and safety of compression stockings class II and dried horse chestnut seed extract (HCSE, 50 mg aescin, twice daily).
Equivalence of both therapies was examined in a novel hierarchical statistical design in 240 patients with chronic venous insufficiency. Patients were treated over a period of 12 weeks in a randomised, partially blinded, placebo-controlled, parallel study design.
Lower leg volume of the more severely affected limb decreased on average by 43.8 mL (n = 95) with HCSE and 46.7 mL (n = 99) with compression therapy, while it increased by 9.8 mL with placebo (n = 46) after 12 weeks therapy for the intention-to-treat group (95% CI: HCSE: 21.1-66.4; compression: 30.4-63.0; placebo: 40.0-20.4). Significant oedema reductions were achieved by HCSE (p = 0.005) and compression (p = 0.002) compared to placebo, and the two therapies were shown to be equivalent (p = 0.001); in this design, however, compression could not be proven as standard with regard to oedema reduction in the statistical test procedure. Both HCSE and compression therapy were well tolerated and no serious treatment-related events were reported.
These results indicate that compression stocking therapy and HCSE therapy are alternative therapies for the effective treatment of patients with oedema resulting from chronic venous insufficiency.
静脉系统疾病是常见疾病,有时与现代文明相关,是社会和职业医学主要关注的问题之一。本研究旨在比较二级压力袜与干燥马栗种子提取物(HCSE,50毫克七叶皂苷,每日两次)的疗效(减轻水肿)和安全性。
在240例慢性静脉功能不全患者中,采用一种新颖的分层统计设计来检验两种疗法的等效性。患者在一项随机、部分盲法、安慰剂对照、平行研究设计中接受为期12周的治疗。
在意向性治疗组中,治疗12周后,病情较重肢体的小腿体积平均减少量,HCSE组为43.8毫升(n = 95),压力治疗组为46.7毫升(n = 99),而安慰剂组增加了9.8毫升(n = 46)(95%置信区间:HCSE:21.1 - 66.4;压力治疗:30.4 - 63.0;安慰剂:40.0 - 20.4)。与安慰剂相比,HCSE(p = 0.005)和压力治疗(p = 0.002)均显著减轻了水肿,且两种疗法显示等效(p = 0.001);然而,在该设计中,在统计检验程序方面,压力治疗在减轻水肿方面未被证明为标准疗法。HCSE和压力治疗耐受性均良好,未报告严重的治疗相关事件。
这些结果表明,压力袜疗法和HCSE疗法是有效治疗慢性静脉功能不全所致水肿患者的替代疗法。